Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

230 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized, phase III trial of sequential epirubicin and docetaxel versus epirubicin alone in postmenopausal patients with node-positive breast cancer.
Coombes RC, Bliss JM, Espie M, Erdkamp F, Wals J, Tres A, Marty M, Coleman RE, Tubiana-Mathieu N, den Boer MO, Wardley A, Kilburn LS, Cooper D, Thomas MW, Reise JA, Wilkinson K, Hupperets P. Coombes RC, et al. Among authors: espie m. J Clin Oncol. 2011 Aug 20;29(24):3247-54. doi: 10.1200/JCO.2010.32.7254. Epub 2011 Jul 18. J Clin Oncol. 2011. PMID: 21768453 Clinical Trial.
[Risk factors in adenocarcinoma of the breast].
Marty M, Espié M, Gorins A. Marty M, et al. Among authors: espie m. Pathol Biol (Paris). 1992 Nov;39(9):923-4. Pathol Biol (Paris). 1992. PMID: 1538935 French. No abstract available.
Phase I study of oxaliplatin in patients with advanced cancer.
Extra JM, Espie M, Calvo F, Ferme C, Mignot L, Marty M. Extra JM, et al. Among authors: espie m. Cancer Chemother Pharmacol. 1990;25(4):299-303. doi: 10.1007/BF00684890. Cancer Chemother Pharmacol. 1990. PMID: 2295116
Taxoids: a new class of cytotoxic agents.
Marty M, Extra JM, Giacchetti S, Cuvier C, Espie M. Marty M, et al. Among authors: espie m. Nouv Rev Fr Hematol (1978). 1994;36 Suppl 1:S25-8. Nouv Rev Fr Hematol (1978). 1994. PMID: 7909941 Review.
Adjuvant cyclophosphamide, methotrexate, and fluorouracil versus fluorouracil, epirubicin, and cyclophosphamide chemotherapy in premenopausal women with axillary node-positive operable breast cancer: results of a randomized trial. The International Collaborative Cancer Group.
Coombes RC, Bliss JM, Wils J, Morvan F, Espié M, Amadori D, Gambrosier P, Richards M, Aapro M, Villar-Grimalt A, McArdle C, Pérez-López FR, Vassilopoulos P, Ferreira EP, Chilvers CE, Coombes G, Woods EM, Marty M. Coombes RC, et al. Among authors: espie m. J Clin Oncol. 1996 Jan;14(1):35-45. doi: 10.1200/JCO.1996.14.1.35. J Clin Oncol. 1996. PMID: 8558217 Clinical Trial.
230 results